Return On Equity of Kymera Therapeutics, Inc. from 31 Dec 2020 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Kymera Therapeutics, Inc. quarterly and annual Return On Equity in % history and change rate from 31 Dec 2020 to 30 Sep 2025.
  • Kymera Therapeutics, Inc. Return On Equity for the quarter ending 30 Sep 2025 was -33%, a 34% decline year-over-year.
  • Kymera Therapeutics, Inc. annual Return On Equity for 2024 was -29%, a 18% increase from 2023.
  • Kymera Therapeutics, Inc. annual Return On Equity for 2023 was -35%, a 2.9% decline from 2022.
  • Kymera Therapeutics, Inc. annual Return On Equity for 2022 was -34%, a 25% decline from 2021.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

Kymera Therapeutics, Inc. Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -33% -8.4% -34% 01 Jul 2025 30 Sep 2025
Q2 2025 -32% -2.7% -9.5% 01 Apr 2025 30 Jun 2025
Q1 2025 -30% +1.8% +5.7% 01 Jan 2025 31 Mar 2025
Q4 2024 -29% +6.2% +18% 01 Oct 2024 31 Dec 2024
Q3 2024 -25% +13% +34% 01 Jul 2024 30 Sep 2024
Q2 2024 -29% +4.3% +13% 01 Apr 2024 30 Jun 2024
Q1 2024 -32% +2.2% +6.5% 01 Jan 2024 31 Mar 2024
Q4 2023 -35% -0.98% -2.9% 01 Oct 2023 31 Dec 2023
Q3 2023 -38% -3.4% -9.8% 01 Jul 2023 30 Sep 2023
Q2 2023 -33% -1.6% -5.2% 01 Apr 2023 30 Jun 2023
Q1 2023 -34% -3.8% -12% 01 Jan 2023 31 Mar 2023
Q4 2022 -34% -6.7% -25% 01 Oct 2022 31 Dec 2022
Q3 2022 -34% -9.9% -41% 01 Jul 2022 30 Sep 2022
Q2 2022 -32% -11% -50% 01 Apr 2022 30 Jun 2022
Q1 2022 -30% -4.8% -19% 01 Jan 2022 31 Mar 2022
Q4 2021 -27% +21% +44% 01 Oct 2021 31 Dec 2021
Q3 2021 -24% 01 Jul 2021 30 Sep 2021
Q2 2021 -21% 01 Apr 2021 30 Jun 2021
Q1 2021 -26% 01 Jan 2021 31 Mar 2021
Q4 2020 -48% 01 Oct 2020 31 Dec 2020

Kymera Therapeutics, Inc. Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2024 -29% +6.2% +18% 01 Jan 2024 31 Dec 2024
2023 -35% -0.98% -2.9% 01 Jan 2023 31 Dec 2023
2022 -34% -6.7% -25% 01 Jan 2022 31 Dec 2022
2021 -27% +21% +44% 01 Jan 2021 31 Dec 2021
2020 -48% 01 Jan 2020 31 Dec 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.